• Small Molecules
    • Biologics
    • Other Drug Modalities
    • SynVent Integrated Drug Discovery
      • SynVent Integrated Drug Discovery

        SynVent is Syngene’s platform for fully integrated therapeutic discovery and development across large and small molecules. 

    • Industries
    • Emerging Biopharma
      • Emerging Biopharma

        Emerging biopharma work at the forefront of science, often venturing into disease areas where little or no real-world data exists to work with or regulatory frameworks to work within.

    • Dedicated Centers
      • Dedicated Centers

        Our Dedicated Centers offer dedicated multi-disciplinary scientific teams, support personnel, and a tailormade ring-fenced and fire-walled infrastructure as per client specifications to support their  R&D  goals

    • Center for Advanced Protein Studies (CAPS)
      • Center for Advanced Protein Studies (CAPS)

        Centre for Advanced Protein Studies [CAPS] is a state-of-the-art advanced national facility located in the Syngene campus, Bangalore.

  • Careers

Leadership

Gaurav Kushwaha
Chief Technology Officer

Gaurav leads the development and execution of our AI and digital transformation strategy, driving smarter, faster, and scalable operations across the entire value chain.

He brings over 24 years of rich experience in IT and digital transformation across diverse industries, including telecom, banking, defence, pharmaceuticals, and manufacturing. He has consistently leveraged technology to drive strategic business outcomes, delivering significant EBITDA impact and operational efficiencies.

Gaurav holds certifications in Six Sigma, TOGAF, and ISO 27001/38500, and has completed executive programs in digital leadership from INSEAD and ISB.

To view or email, Please share your details view

Your browser does not support this function.

To download, Please share your details

To view or email, Please share your details view

To download, Please share your details